- Home
- Publications
- Publication Search
- Publication Details
Title
Medicinal use of cannabis based products and cannabinoids
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages l1141
Publisher
BMJ
Online
2019-04-04
DOI
10.1136/bmj.l1141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
- (2018) Radmila Pavlovic et al. MOLECULES
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions
- (2018) Emily Stockings et al. PAIN
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Restrictions on drugs with medical value: Moving beyond stalemate
- (2018) Tom P Freeman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Phytocannabinoids: a unified critical inventory
- (2016) Lumír Ondřej Hanuš et al. NATURAL PRODUCT REPORTS
- Keep off the grass? Cannabis, cognition and addiction
- (2016) H. Valerie Curran et al. NATURE REVIEWS NEUROSCIENCE
- Spice and all things nasty: the challenge of synthetic cannabinoids
- (2016) Nicola J Kalk et al. BMJ-British Medical Journal
- Spice and all things nasty: the challenge of synthetic cannabinoids
- (2016) Nicola J Kalk et al. BMJ-British Medical Journal
- Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15
- (2015) Raymond J. M. Niesink et al. ADDICTION
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started